These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 534166)

  • 1. [Comparative action of L-dopa and bromocriptine on thyreostimulating hormone (T.S.H.) in primary hypothyroïdism (author's transl)].
    Lefebvre J; Loeuille GA; Steinling M; Linquette M
    Nouv Presse Med; 1979 Oct; 8(38):3033-6. PubMed ID: 534166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of L-dopa and bromocriptine on calcitonin secretion in medullary thyroid carcinoma.
    Spiler IJ; Kapcala LP; Graze K; Gagel RF; Feldman ZT; Biller B; Tashjian AH; Reichlin S
    J Clin Endocrinol Metab; 1980 Oct; 51(4):806-9. PubMed ID: 7419666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Response of hGH to insulin hypoglycemia and to bromocriptine before and after the administration of L-dopa in primary hypothyroidism].
    Campino C; Pumarino H; Michelsen H; Piraino P; Generini G; Bruggendieck B
    Rev Med Chil; 1985 Apr; 113(4):296-300. PubMed ID: 3915142
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies of the thyrotropic function of the adenopituitary of the offspring of rats treated during pregnancy with dopaminergic agents.
    Boyadjieva M; Zaharieva B; Ovtcharov R
    Acta Physiol Pharmacol Bulg; 1988; 14(3):63-6. PubMed ID: 3223296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome.
    Prelević GM; Würzburger MI; Perić LA
    J Endocrinol Invest; 1987 Aug; 10(4):389-95. PubMed ID: 3119696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
    Hanew K; Sasaki A; Sato S; Goh M; Yoshinaga K
    J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of L-dopa on plasma TSH levels in primary hypothyroidism.
    Minozzi M; Faggiano M; Lombardi G; Carella C; Criscuolo T; Scapagnini U
    Neuroendocrinology; 1975; 17(2):147-53. PubMed ID: 1134620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for dopaminergic stimulation of growth velocity in some hypopituitary children.
    Huseman CA; Hassing JM
    J Clin Endocrinol Metab; 1984 Mar; 58(3):419-25. PubMed ID: 6420440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bromocryptin effect on growth hormone and prolactin secretion after administration of thyrotropin-releasing hormone in patients with primary hypothyroidism and acromegaly (author's transl)].
    Felt V; Nedvídková J; Krejcík L; Hainer V
    Cas Lek Cesk; 1977 May; 116(19):591-4. PubMed ID: 406999
    [No Abstract]   [Full Text] [Related]  

  • 10. De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset.
    Pearce RK; Banerji T; Jenner P; Marsden CD
    Mov Disord; 1998 Mar; 13(2):234-41. PubMed ID: 9539335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing bromocriptine effects with levodopa effects on bladder function in Parkinson's disease.
    Uchiyama T; Sakakibara R; Yamamoto T; Ito T; Yamaguchi C; Awa Y; Yano M; Yanagisawa M; Kobayashi M; Higuchi Y; Ichikawa T; Yamanishi T; Hattori T; Kuwabara S
    Mov Disord; 2009 Dec; 24(16):2386-90. PubMed ID: 19908315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of L dopa, dopamine and CB 154 on prolactin secretion from human pituitary adenomas in vitro (proceedings) (author's transl)].
    Peillon F; Cesselin F; Zygelman N; Brandi A; Mauborgne A
    Ann Endocrinol (Paris); 1978; 39(3):255-7. PubMed ID: 718128
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of chronic bromocriptine and levodopa administration on cerebral type 1 cannabinoid receptor binding.
    Casteels C; Vanbilloen B; Vercammen D; Bosier B; Lambert DM; Bormans G; Van Laere K
    Synapse; 2010 Aug; 64(8):617-23. PubMed ID: 20340169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No effects of l-dopa and bromocriptine on psychophysiological parameters of human selective attention.
    Oranje B; Gispen-de Wied CC; Westenberg HG; Kemner C; Verbaten MN; Kahn RS
    J Psychopharmacol; 2006 Nov; 20(6):789-98. PubMed ID: 16478755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromocriptine reduces augmented thyrotropin secretion in obese premenopausal women.
    Kok P; Roelfsema F; Frölich M; van Pelt J; Meinders AE; Pijl H
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1176-81. PubMed ID: 19190107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing dopaminergic activity: effects of L-dopa and bromocriptine on human sensory gating.
    Oranje B; Gispen-de Wied CC; Westenberg HG; Kemner C; Verbaten MN; Kahn RS
    J Psychopharmacol; 2004 Sep; 18(3):388-94. PubMed ID: 15358983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth enhancement by dopaminergic therapy in children with intrauterine growth retardation.
    Huseman CA
    J Clin Endocrinol Metab; 1985 Sep; 61(3):514-9. PubMed ID: 3926809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
    Henry B; Crossman AR; Brotchie JM
    Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term results of treatment of Parkinson's disease with bromocriptine and domperidone (author's transl)].
    Agid Y; Quinn N; Lhermitte F
    Rev Neurol (Paris); 1981; 137(1):49-51. PubMed ID: 7232966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of bromocryptine on the secretion of thyrotropic hormone, triiodothyronine, and thyroxine in patients with hypothyroidism].
    Felt V; Nedvídková J
    Vnitr Lek; 1977 Sep; 23(9):868-70. PubMed ID: 411252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.